SD BIOTECHNOLOGIES

닫기

SD
BIOTECHNOLOGIES

All Menu Close

Balance Sheet

( Unit : million )

Balance Sheet
Item 2017 Y 12 M 2016 Y 12 M 2015 Y 12 M
Price Composition
ratio
Fluctuation
rate
Price Composition
ratio
Fluctuation
rate
Price Composition
ratio
Fluctuation
rate
TOTAL CURRENT ASSETS 72,749 57 75 % 41,444 61 51 % 27,443 65 493 %
TOTAL NON-CURRENT ASSETS 53,332 42 103 % 26,203 38 77 % 14,749 35 5197 %
TOTAL ASSETS 126,081 100 86 % 67,647 100 60 % 42,192 100 759 %
TOTAL CURRENT LIABILITIES 12,230 9 9 % 11,137 16 9 % 10,174 24 310 %
TOTAL NON-CURRENT LIABILITIES 419 0 -59 % 1,040 1 -32 % 1,537 3 2268 %
TOTAL LIABILITIES 12,650 10 3 % 12,177 18 4 % 11,711 27 360 %
Capital stocks 11,032 8 17 % 9,432 13 300 % 2,358 5 489 %
Capital surplus 36,238 28 4508 % 786 1 -90 % 7,895 18 0 %
Retained earnings 65,143 51 46 % 44,625 66 121 % 20,174 47 932 %
TOTAL STOCKHOLDERS' EQUITY 113,431 90 104 % 55,470 82 82 % 30,481 72 1190 %

Income Statement

( Unit : million )

Income Statement
Item 2017 Y 2016 Y 2015 Y
Price Fluctuation
rate
Price Fluctuation
rate
Price Fluctuation
rate
SALES(NET) 102,299 0 % 102,028 36 % 74,656 670 %
GROSS PROFIT 54,848 -12 % 62,587 42 % 44,079 1016 %
OPERATING INCOME 26,499 -13 % 30,463 14 % 26,600 767 %
NON-OPERATING INCOME 1,432 18 % 1,212 62 % 748 3189 %
NON-OPERATING EXPENSES 1,732 235 % 517 -82 % 3,021 6954 %
NET INCOME 20,518 -16 % 24,451 33 % 18,361 613 %

Cash Flow Statement

( Unit : million )

Cash Flow Statement
Item 2017 Y 12 M 2016 Y 12 M 2015 Y 12 M
Unit Fluctuation
rate
Unit Fluctuation
rate
Unit Fluctuation
rate
Cash flows from operating activities -1,029 -106 % 15,239 -31 % 22,361 0 %
Cash flows from investing activities -43,232 -208 % -14,044 40 % -23,397 0 %
CF from financing act. 36,431 8261 % -407 -104 % 8,680 0 %
Increases(Decreases) in cash -7,830 -1094 % 788 -89 % 7,644 0 %
Cash at the beginning of the period 10,097 8 % 9,316 468 % 1,640 0 %
Cash at the end of the period 2,126 -78 % 10,097 8 % 9,316 0 %

※ The above data are based on separate financial statements.